Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow
- PMID: 30670816
- PMCID: PMC6460362
- DOI: 10.1038/s41401-019-0210-3
Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow
Conflict of interest statement
The authors declare no competing interests.
References
-
- Viudez-Martinez A, Garcia-Gutierrez MS, Medrano-Relinque J, Navarron CM, Navarrete F, Manzanares J. Cannabidiol does not display drug abuse potential in mice behavior. Acta Pharmacol Sin. 2019;40:358–64. https://doi.org/s41401-018-0032-8. - PMC - PubMed
-
- Bian YM, He XB, Jing YK, Wang LR, Wang JM, Xie XQ. Computational systems pharmacology analysis of cannabidiol: a combination of chemogenomics-knowledgebase network analysis and integrated in silico modeling and simulation. Acta Pharmacol Sin. 2019;40:374–86. https://doi.org/s41401-018-0071-1. - PMC - PubMed
-
- Laun AS, Shrader SH, Brown KJ, Song ZH. GPR3. GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol. Acta Pharmacol Sin. 2019;40:300–8. https://doi.org/s41401-018-0031-9. - PMC - PubMed
-
- Scherma M, Masia P, Satta V, Fratta W, Fadda P, Tanda G. Brain activity of anandamide: a rewarding bliss? Acta Pharmacol Sin. 2019;40:309–23. https://doi.org/s41401-018-0075-x. - PMC - PubMed
-
- He XH, Jordan CJ, Vemuri K, Bi GH, Zhan J, Gardner EL, et al. Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats. Acta Pharmacol Sin. 2019;40:365–73. https://doi.org/s41401-018-0059-x. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
